[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100088575":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":24,"responsibleParty":39,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":7,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"The HIV Netherlands Australia Thailand Research Collaboration","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Praphan Phanuphak, MD, PhD","HIV-NAT, Thai Red Cross AIDS Research Center","PRINCIPAL_INVESTIGATOR",[14,20],{"name":15,"role":16,"phone":17,"phoneExt":18,"email":19},"Anchalee Avihingsanon, MD, PhD","CONTACT","66 2 2557334-5","107","anchalee.a@hivnat.org",{"name":21,"role":16,"phone":17,"phoneExt":22,"email":23},"Stephen Kerr, PhD","138","s.kerr@unsw.edu.au",[25],{"facility":11,"status":26,"city":27,"state":7,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Bangkok","10330","Thailand","TH",{"type":32,"coordinates":33},"Point",[34,35],100.50144,13.75398,{"lat":35,"lon":34},[38],{"name":10,"role":12,"phone":7,"phoneExt":7,"email":7},{"type":40,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100088575","a-long-term-follow-up-of-the-hiv-nat-cohort-100088575",false,"NCT00411983","A Long-term Follow-up of the HIV-NAT Cohort","A Long-term Follow-up Study for HIV-infected Individuals Who Have Participated in HIV-NAT Study Protocols","Inclusion Criteria:\n\n* HIV infected patients( children and adults) previously participated HIV-NAT studies\n* HIV infected patients( children and adults) currently participate in HIV-NAT trials\n* Able to provide written consent\n\nExclusion Criteria:\n\n* Unable to provide written consent","ALL","18 Years",{"count":51,"type":52},10000,"ESTIMATED","OBSERVATIONAL","With HIV\u002FAIDS increasingly considered a chronic disease, 24-, or 48-week data from antiretroviral studies are no longer sufficient. Only with long-term follow-up and outcome data will shed some much-needed light on the answers of questions that have stumped us for several years. Data from a large observational cohort of patients treated with combination antiretroviral therapy will provide further insights into the long-term safety and durability of various antiretroviral therapeutic approached, the efficacy of HIV viral load and CD4 cell counts as predictors of disease progression and mortality, and the importance of adherence.",[56],"HIV Infections",[58,59],"chronic HIV infection","long term cohort of HIV infection","2025-03-14",{"date":62,"type":63},"2025-03-17","ACTUAL",{"date":65,"type":63},"2002-11",{"date":67,"type":52},"2030-12",{"name":5,"class":6},1]